Statement of Changes in Beneficial Ownership (4)

FORM 4

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden
hours per response...

0.5

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Cordani David	2. Issuer Name and Ticker or Trading Symbol Cigna Corp [ CI ]	5. Relationship of Reporting Person(s) to Issuer (Check all applicable) __X__ Director                    _____ 10% Owner __X__ Officer (give title below)    _____ Other (specify below) President & CEO
(Last)          (First)          (Middle) 900 COTTAGE GROVE ROAD	3. Date of Earliest Transaction (MM/DD/YYYY) 5/4/2021
(Street) BLOOMFIELD, CT 06002 (City)        (State)        (Zip)	4. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security (Instr. 3)	2. Trans. Date	2A. Deemed Execution Date, if any	3. Trans. Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $.01 Par Value	5/4/2021		M(1)		42772.0000	A	$78.0350	140253.0000	D
Common Stock, $.01 Par Value	5/4/2021		S(1)		379.0000	D	$259.1934 (2)	139874.0000	D
Common Stock, $.01 Par Value	5/4/2021		S(1)		1367.0000	D	$256.4266 (3)	138507.0000	D
Common Stock, $.01 Par Value	5/4/2021		S(1)		3325.0000	D	$258.4242 (4)	135182.0000	D
Common Stock, $.01 Par Value	5/4/2021		S(1)		5510.0000	D	$257.5190 (5)	129672.0000	D
Common Stock, $.01 Par Value	5/4/2021		S(1)		32191.0000	D	$255.1274 (6)	97481.0000	D
Common Stock, $.01 Par Value	5/5/2021		M(1)		14237.0000	A	$78.0350	111718.0000	D
Common Stock, $.01 Par Value								1647.1673 (7)	I	By 401(k)
Common Stock, $.01 Par Value								424611.0000	I	By GRAT

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Trans. Date	3A. Deemed Execution Date, if any	4. Trans. Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (Right to Buy)	$78.0350	5/4/2021		M (1)			42772.0000	2/26/2015 (8)	2/26/2024	Common Stock, $.01 Par Value	42772.0000	$0.0000	90718.0000	D
Employee Stock Option (Right to Buy)	$78.0350	5/5/2021		M (1)			14237.0000	2/26/2015 (8)	2/26/2024	Common Stock, $.01 Par Value	14237.0000	$0.0000	76481.0000	D

Explanation of Responses:
(1)	These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2021.
(2)	Represents the weighted average price of the shares sold. The prices actually received ranged from $259.015 to $259.39 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
(3)	Represents the weighted average price of the shares sold. The prices actually received ranged from $256.00 to $256.975 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
(4)	Represents the weighted average price of the shares sold. The prices actually received ranged from $258.00 to $258.99 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
(5)	Represents the weighted average price of the shares sold. The prices actually received ranged from $257.00 to $257.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
(6)	Represents the weighted average price of the shares sold. The prices actually received ranged from $255.00 to $255.98 per share. The reporting person will provide to the issuer, any security holder of the issuer, or the Securities and Exchange Commission, upon request, information regarding the number of shares sold at each price within the range.
(7)	Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
(8)	This option was granted on February 26, 2014. The option vested in three equal annual installments on the first, second and third anniversaries of the grant date.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Cordani David 900 COTTAGE GROVE ROAD BLOOMFIELD, CT 06002	X		President & CEO

Signatures
By: Jill M. Stadelman, attorney-in-fact		5/6/2021
**Signature of Reporting Person		Date